Fecal Microbiota Transplantation Is Effective for the Treatment of Partially Treated Clostridioides difficile Infection

참고문헌 (9)

1. Quraishi MN, "Systematic review with meta-analysis : the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection", Aliment Pharmacol Ther, 46, pp.479~493 (2017)
2. Lagier JC, "Dramatic reduction in Clostridium difficile ribotype 027-associated mortality with early fecal transplantation by the nasogastric route : a preliminary report", Eur J Clin Microbiol Infect Dis, 34, pp.1597~1601 (2015)
3. Haifer C, "Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice", Gut, 69, pp.801~810 (2020)
4. Yoon Hyuk, "Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with Clostridioides difficile Infection", Gut and Liver, 15(1), pp.61~69 (2021), 거트앤리버 소화기연관학회협의회[DOI]
5. Juul FE, "Fecal microbiota transplantation for primary Clostridium difficile infection", N Engl J Med, 378, pp.2535~2536 (2018)
6. Ng SC, "Scientific frontiers in faecal microbiota transplantation : joint document of AsiaPacific Association of Gastroenterology(APAGE)and AsiaPacific Society for Digestive Endoscopy(APSDE)", Gut, 69, pp.83~91 (2020)
7. Cammarota G, "International consensus conference on stool banking for faecal microbiota transplantation in clinical practice", Gut, 68, pp.2111~2121 (2019)
8. Ianiro G, "Reorganisation of faecal microbiota transplant services during the COVID-19pandemic", Gut, 69, pp.1555~1563 (2020)
9. Khanna S, "Fecal microbiota transplantation for recurrent Clostridioides difficile infection : the COVID-19 era", Am J Gastroenterol, 115, pp.971~974 (2020)

관련 논문AI추천